BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30887252)

  • 1. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
    Nasreddine G; El-Sibai M; Abi-Habib RJ
    Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
    Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
    J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.
    Swayden M; Bekdash A; Fakhoury I; El-Atat O; Borjac-Natour J; El-Sibai M; Abi-Habib RJ
    Hum Cell; 2021 Jan; 34(1):152-164. PubMed ID: 32979152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.
    Khalil N; Abi-Habib RJ
    Invest New Drugs; 2020 Oct; 38(5):1236-1246. PubMed ID: 31823161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
    Tanios R; Bekdash A; Kassab E; Stone E; Georgiou G; Frankel AE; Abi-Habib RJ
    Leuk Res; 2013 Nov; 37(11):1565-71. PubMed ID: 24018014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
    El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
    J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
    Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
    Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
    Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.
    El-Mais N; Fakhoury I; Al Haddad M; Nohra S; Abi-Habib R; El-Sibai M
    Pancreas; 2021 Sep; 50(8):1187-1194. PubMed ID: 34714283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis.
    Delage B; Luong P; Maharaj L; O'Riain C; Syed N; Crook T; Hatzimichael E; Papoudou-Bai A; Mitchell TJ; Whittaker SJ; Cerio R; Gribben J; Lemoine N; Bomalaski J; Li CF; Joel S; Fitzgibbon J; Chen LT; Szlosarek PW
    Cell Death Dis; 2012 Jul; 3(7):e342. PubMed ID: 22764101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
    Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
    Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprivation of arginine by recombinant human arginase in prostate cancer cells.
    Hsueh EC; Knebel SM; Lo WH; Leung YC; Cheng PN; Hsueh CT
    J Hematol Oncol; 2012 Apr; 5():17. PubMed ID: 22546217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment.
    Yu KM; Pang TP; Cutler M; Tian M; Huang L; Lau JY; Chung SF; Lo TW; Leung TY
    Life Sci; 2021 Jan; 264():118674. PubMed ID: 33129876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
    Xu S; Lam SK; Cheng PN; Ho JC
    Cancer Sci; 2018 Nov; 109(11):3471-3482. PubMed ID: 30155941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
    Syed N; Langer J; Janczar K; Singh P; Lo Nigro C; Lattanzio L; Coley HM; Hatzimichael E; Bomalaski J; Szlosarek P; Awad M; O'Neil K; Roncaroli F; Crook T
    Cell Death Dis; 2013 Jan; 4(1):e458. PubMed ID: 23328665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas.
    Bean GR; Kremer JC; Prudner BC; Schenone AD; Yao JC; Schultze MB; Chen DY; Tanas MR; Adkins DR; Bomalaski J; Rubin BP; Michel LS; Van Tine BA
    Cell Death Dis; 2016 Oct; 7(10):e2406. PubMed ID: 27735949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
    Hassabo AA; Abdelraof M; Allam RM
    Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.
    Li YY; Wu C; Chen SM; Shah SS; Wangpaichitr M; Feun LG; Kuo MT; Suarez M; Prince J; Savaraj N
    Oncotarget; 2016 Apr; 7(14):17665-80. PubMed ID: 26771234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
    Delage B; Fennell DA; Nicholson L; McNeish I; Lemoine NR; Crook T; Szlosarek PW
    Int J Cancer; 2010 Jun; 126(12):2762-72. PubMed ID: 20104527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.